GB201911868D0 - Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders - Google Patents

Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Info

Publication number
GB201911868D0
GB201911868D0 GBGB1911868.6A GB201911868A GB201911868D0 GB 201911868 D0 GB201911868 D0 GB 201911868D0 GB 201911868 A GB201911868 A GB 201911868A GB 201911868 D0 GB201911868 D0 GB 201911868D0
Authority
GB
United Kingdom
Prior art keywords
treatment
pharmaceutical compositions
novel compounds
inflammatory disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1911868.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galapagos NV
Original Assignee
Galapagos NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos NV filed Critical Galapagos NV
Priority to GBGB1911868.6A priority Critical patent/GB201911868D0/en
Publication of GB201911868D0 publication Critical patent/GB201911868D0/en
Priority to PCT/EP2020/072715 priority patent/WO2021032582A1/en
Priority to EP20760394.5A priority patent/EP4017590A1/en
Priority to TW109128024A priority patent/TW202115060A/en
Priority to ARP200102344A priority patent/AR119792A1/en
Ceased legal-status Critical Current

Links

GBGB1911868.6A 2019-08-19 2019-08-19 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Ceased GB201911868D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB1911868.6A GB201911868D0 (en) 2019-08-19 2019-08-19 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
PCT/EP2020/072715 WO2021032582A1 (en) 2019-08-19 2020-08-13 Pyrazolo[4,3-c]pyridine derivatives and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP20760394.5A EP4017590A1 (en) 2019-08-19 2020-08-13 Pyrazolo[4,3-c]pyridine derivatives and pharmaceutical compositions thereof for the treatment of inflammatory disorders
TW109128024A TW202115060A (en) 2019-08-19 2020-08-18 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
ARP200102344A AR119792A1 (en) 2019-08-19 2020-08-19 PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY PATHOLOGIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1911868.6A GB201911868D0 (en) 2019-08-19 2019-08-19 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
GB201911868D0 true GB201911868D0 (en) 2019-10-02

Family

ID=68099572

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1911868.6A Ceased GB201911868D0 (en) 2019-08-19 2019-08-19 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Country Status (5)

Country Link
EP (1) EP4017590A1 (en)
AR (1) AR119792A1 (en)
GB (1) GB201911868D0 (en)
TW (1) TW202115060A (en)
WO (1) WO2021032582A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4091449A1 (en) * 2021-05-19 2022-11-23 Syngenta Crop Protection AG Weed control method
TW202317561A (en) * 2021-07-01 2023-05-01 美商羅曼德生物治療公司 Compounds having 1h-pyrazolo[4,3-c]pyridin-6-amino as therapeutic agents
CN115557947B (en) * 2021-07-02 2024-04-02 成都百裕制药股份有限公司 Pyrazolo [4,3-c ] pyridine derivative and application thereof in medicine
WO2023161327A1 (en) * 2022-02-24 2023-08-31 Galapagos Nv Compound for use in and methods of treatment of inflammatory diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3235B1 (en) * 2006-05-26 2018-03-08 Astex Therapeutics Ltd Pyrrolopyrimidine compounds and their uses
AU2009211338B2 (en) * 2008-02-06 2011-12-15 Novartis Ag Pyrrolo[2, 3-D] pyrimidines and use thereof as tyrosine kinase inhibitors
WO2013017480A1 (en) * 2011-07-29 2013-02-07 Cellzome Limited Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors

Also Published As

Publication number Publication date
TW202115060A (en) 2021-04-16
AR119792A1 (en) 2022-01-12
WO2021032582A1 (en) 2021-02-25
EP4017590A1 (en) 2022-06-29

Similar Documents

Publication Publication Date Title
ZA202004025B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL255109A0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201911868D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
ZA202002166B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL288375A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201610056D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
IL279397A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP4081201A4 (en) Pharmaceutical composition for treatment or prevention of multiple inflammatory disorders
IL286677A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL286688A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201610055D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL286685A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201702603D0 (en) Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL285751A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB202001421D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB202001420D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201807222D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammation disorders
GB201905536D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of metabolic disorders
GB201817344D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201817343D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201702604D0 (en) Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201809836D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL287392A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases
GB201814764D0 (en) Pharmaceutical compositions for the treatment of proteinopathies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)